Skip to content

Bryan L. Roth

National Institute of Mental Health, University of North Carolina at Chapel Hill

60 papers in the library · 5,431 citations · publishing 2001-2026

Papers

Sort Most recent Most cited

SAR of psilocybin analogs: Discovery of a selective 5-HT2C agonist

Bioorganic & Medicinal Chemistry Letters August 3, 2005 Howard Sard, Govindaraj Kumaran, Cynthia Morency et al. 78 citations

An SAR study of psilocybin and psilocin derivatives reveals that 1-methylpsilocin is a selective agonist at the h5-HT(2C) receptor. The corresponding phosphate derivative, 1-methylpsilocybin, shows efficacy in an animal model for obsessive-compulsive disorder, as does 4-fluoro-N,N-dimethyltryptamine. These results suggest a new area for development of novel 5-HT(2C) agonists with applications...

DOI: 10.1016/j.bmcl.2005.06.104 (opens in new tab) Psilocybin Agonist Pharmacology Hallucinogen +2

Identification of the molecular mechanisms by which the diterpenoid salvinorin A binds to kappa-opioid receptors.

Biochemistry June 21, 2005 Feng Yan, Philip D Mosier, Richard B Westkaemper et al. 91 citations

Salvinorin A is a naturally occurring hallucinogenic diterpenoid from the plant Salvia divinorumthat selectively and potently activates kappa-opioid receptors (KORs). Salvinorin A is unique in that it is the only known lipid-like molecule that selectively and potently activates a G-protein coupled receptor (GPCR), which has as its endogenous agonist a peptide; salvinorin A is also the only...

DOI: 10.1021/bi050490d (opens in new tab) Full text (opens in new tab) Opioid receptors Opioid receptor binding Receptor activation Receptor selectivity +18

Studies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonist.

Journal of Medicinal Chemistry January 27, 2005 Thomas A Munro, Mark A Rizzacasa, Bryan L. Roth et al.

Salvinorin A (1), from the sage Salvia divinorum, is a potent and selective kappa opioid receptor (KOR) agonist. We screened other salvinorins and derivatives for binding affinity and functional activity at opioid receptors. Our results suggest that the methyl ester and furan ring are required for activity but that the lactone and ketone functionalities are not. Other salvinorins showed...

Salvinorin A: a novel and highly selective kappa-opioid receptor agonist.

Life Sciences October 15, 2004 Feng Yan, Bryan L. Roth 68 citations

kappa-opioid receptors (KORs) represent the principal site of action of dynorphin and related neuropeptides. Recently, Salvinorin A--a naturally occurring neoclerodane diterpene hallucinogen was identified to be a highly selective KOR agonist. In this brief review we summarize the known chemistry, pharmacology and biology of salvinorin A. Because salvinorin A profoundly alters human...

Screening the receptorome to discover the molecular targets for plant-derived psychoactive compounds: a novel approach for CNS drug discovery.

Pharmacology & Therapeutics May 1, 2004 Bryan L. Roth, Estela Lopez, Scott Beischel et al. 98 citations

Because psychoactive plants exert profound effects on human perception, emotion, and cognition, discovering the molecular mechanisms responsible for psychoactive plant actions will likely yield insights into the molecular underpinnings of human consciousness. Additionally, it is likely that elucidation of the molecular targets responsible for psychoactive drug actions will yield validated...

DOI: 10.1016/j.pharmthera.2004.03.004 (opens in new tab) Full text (opens in new tab) Cns drug discovery Neuroscience drug discovery Psychopharmacology Neurotherapeutics +16

Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.

Journal of Pharmacology and Experimental Therapeutics March 1, 2004 Charles Chavkin, Sumit Sud, Wenzhen Jin et al. 212 citations

The diterpene salvinorin A from Salvia divinorum has recently been reported to be a high-affinity and selective kappa-opioid receptor agonist (Roth et al., 2002). Salvinorin A and selected derivatives were found to be potent and efficacious agonists in several measures of agonist activity using cloned human kappa-opioid receptors expressed in human embryonic kidney-293 cells. Thus, salvinorin...

3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro.

Molecular Pharmacology June 2003 Vincent Setola, Sandra J Hufeisen, K Jane Grande-Allen et al.

Recent findings have implicated the 5-hydroxytryptamine 2B (5-HT2B) serotonin receptor in mediating the heart valve fibroplasia [valvular heart disease (VHD)] and primary pulmonary hypertension observed in patients taking the now-banned appetite suppressant fenfluramine (Pondimin, Redux). Via large-scale, random screening of a portion of the receptorome, we have discovered that the amphetamine...

Salvinorin A: the "magic mint" hallucinogen finds a molecular target in the kappa opioid receptor.

TIPS - Trends in Pharmacological Sciences March 1, 2003 Douglas J Sheffler, Bryan L. Roth 151 citations

Salvinorin A, a neoclerodane diterpene, is the most potent naturally occurring hallucinogen known and rivals the synthetic hallucinogen lysergic acid diethylamide in potency. Recently, the molecular target of salvinorin A was identified as the kappa opioid receptor (KOR). Salvinorin A represents the only known non-nitrogenous KOR selective agonist. Based on the selectivity of salvinorin A for...

Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.

Proceedings of the National Academy of Sciences September 3, 2002 Bryan L. Roth, Karen Baner, Richard B Westkaemper et al. 782 citations

Salvia divinorum, whose main active ingredient is the neoclerodane diterpene Salvinorin A, is a hallucinogenic plant in the mint family that has been used in traditional spiritual practices for its psychoactive properties by the Mazatecs of Oaxaca, Mexico. More recently, S. divinorum extracts and Salvinorin A have become more widely used in the U.S. as legal hallucinogens. We discovered that...

DOI: 10.1073/pnas.182234399 (opens in new tab) Full text (opens in new tab) Salvinorin a Natural compound Plant compound Kappa opioid receptor +9

Control of Serotonergic Function in Medial Prefrontal Cortex by Serotonin-2A Receptors through a Glutamate-Dependent Mechanism

Journal of Neuroscience December 15, 2001 Raúl Martín‐Ruiz, M. Victoria Puig, Pau Celada et al. 335 citations

We examined the in vivo effects of the hallucinogen 4-iodo-2,5-dimethoxyamphetamine (DOI). DOI suppressed the firing rate of 7 of 12 dorsal raphe (DR) serotonergic (5-HT) neurons and partially inhibited the rest (ED(50) = 20 microg/kg, i.v.), an effect reversed by M100907 (5-HT(2A) antagonist) and picrotoxinin (GABA(A) antagonist). DOI (1 mg/kg, s.c.) reduced the 5-HT release in medial...